Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14525618 | 1.00 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL11961373 | 0.97 | KDM4E (0.33) | MEN1KMT2A | |
| SCHEMBL9681629 | 0.81 | — | — | |
| SCHEMBL14049460 | 0.81 | — | — | |
| SCHEMBL17379189 | 0.81 | — | — | |
| SCHEMBL9062787 | 0.81 | — | — | |
| SCHEMBL27888 | 0.81 | — | — | |
| SCHEMBL9681638 | 0.81 | — | — | |
| SCHEMBL12700285 | 0.80 | CHRM2 (0.34) | — | |
| SCHEMBL22166299 | 0.80 | CHRM2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9427425-B2 | Extracts, fractions and compositions comprising acetogenins and their applications | LAILA NUTRACEUTICALS (IN) | 2016-08-30 | — | — | US | disclosed |
| US-9427425-B2 | Extracts, fractions and compositions comprising acetogenins and their applications | LAILA NUTRACEUTICALS (IN) | 2016-08-30 | — | — | US | disclosed |
| US-20120201884-A1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | LAlLA NUTRACEUTICALS (IN) | 2012-08-09 | — | — | US | disclosed |
| US-20120201884-A1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | LAlLA NUTRACEUTICALS (IN) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120201884-A1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | TNF, IFNG, CXCL10 | MEN1 4280/4885KMT2A 2342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.